LITTLE KNOWN FACTS ABOUT LEAP-2.

nonetheless inactive towards other host microbiota such as Actinobacteria or Bacteroidetes. Ibezapolstat was minimally absorbed while in the hamster product, bringing about high colonic and very low systemic concentrations, and was also shown to get helpful for CDI.ten Preclinical safety testing demonstrated a favourable safety profile.While in the